Stanford Medicine scientists transplanted human brain organoids into newborn mice engineered to lack most of their cerebral cortex, creating functional neural connections. Published online Sept. 16 in Nature, the breakthrough model aims to accelerate research into severe neurological and psychiatric disorders.
Researchers at Stanford University have achieved a major milestone in neurological research by successfully integrating laboratory-grown human brain tissue into mice bioengineered and bred without most of their cerebral cortex and hippocampus. The study, published on September 16, details how these human cortical organoids survived, expanded, and established functional connections with the host animal’s nervous system, including the spinal cord.
Engineering the Xenocortical Mouse Model at Stanford
The experimental setup required specialized genetic engineering to prepare a hospitable cavity in the recipient animals. According to technical documentation in the research, scientists utilized Emx1-cre, Esco2, and C57BL SCID mice to establish a targeted breeding scheme. Because breeders were occasionally prone to parental infanticide, the team implemented an aunting strategy using Swiss Webster active dams supplied by Charles River.
The human tissue originated from induced pluripotent stem cells. These cells were dissociated using Accutase, aggregated in microwells with a ROCK inhibitor, and guided through neural induction using growth factors such as epidermal growth factor, basic fibroblast growth factor, brain-derived neurotrophic factor, and NT-3. Prior to transplantation into 5-to-17-day-old pups, the organoids underwent viral labeling via lentiviruses and rabies tracing vectors.
Unlocking Insights Into Severe Neurodevelopmental Disorders
Human brain tissue has historically proved exceptionally difficult to study directly because the organ is deeply complex and living samples are nearly always inaccessible. By placing these organoids into an intact, living mammalian nervous system, researchers can now observe how disease-associated alterations manifest in real time.
Sergiu Pasca, senior author of the study and director of the Stanford Brain Organogenesis Program, emphasized the value of the new methodology. These animal models offer a unique opportunity to study how disease-associated alterations in human brain circuitry manifest in an intact nervous system,
he said, as noted in Stanford Medicine’s reporting.
“Neuroscientists will be able to learn much more about the causes and mechanisms of neurodevelopmental and pregnancy-incurred disorders and to test possible interventions to correct or prevent them.”
Sergiu Pasca, senior author
Researchers expect the model to speed investigations into conditions like schizophrenia, epilepsy, and cerebral palsy. Alison Singer, president of the Autism Science Foundation, pointed out the severe human toll of these conditions, noting that profoundly autistic patients often face pronounced cognitive disabilities, seizures, and vulnerabilities requiring round-the-clock supervision.
Functional Recovery and Future Scientific Hurdles
Behavioral tests demonstrated tangible functional improvements. According to independent coverage of the findings, the matured grafts formed functional neural circuits that restored much of the mice’s memory performance and improved their movement when compared against control subjects that received no transplant.
Despite the therapeutic potential for drug testing and basic science, the procedure introduces complex ethical questions regarding the integration of human neural tissue into animal hosts. Monitoring animal welfare remains a vital priority as xenocortication research advances.
Продолжение темы
